Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000897069-24-001823
Filing Date
2024-09-09
Accepted
2024-09-09 16:47:22
Documents
1
Effectiveness Date
2024-09-09
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7286
  Complete submission text file 0000897069-24-001823.txt   8560
Mailing Address C/O COMPLIANCE DEPARTMENT 60 EAST 42ND STREET, 28TH FLOOR NEW YORK NY 10165
Business Address C/O COMPLIANCE DEPARTMENT 60 EAST 42ND STREET, 28TH FLOOR NEW YORK NY 10165 (212) 994-7400
iCapital - Blackstone Life Sciences VI Access Fund L.P. (Filer) CIK: 0002023982 (see all company filings)

EIN.: 993004047 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-523561 | Film No.: 241287770